Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.Suryawanshi, AmolNational Institutes of Health (NIH), National Eye Institute (NEI) (ID: 1R15EY035057-01), $453,296USD, 2023-05-01 -- 2026-04-30